» Articles » PMID: 15254578

Molecular Mediators of Hepatic Steatosis and Liver Injury

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2004 Jul 16
PMID 15254578
Citations 789
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity and its associated comorbidities are among the most prevalent and challenging conditions confronting the medical profession in the 21st century. A major metabolic consequence of obesity is insulin resistance, which is strongly associated with the deposition of triglycerides in the liver. Hepatic steatosis can either be a benign, noninflammatory condition that appears to have no adverse sequelae or can be associated with steatohepatitis: a condition that can result in end-stage liver disease, accounting for up to 14% of liver transplants in the US. Here we highlight recent advances in our understanding of the molecular events contributing to hepatic steatosis and nonalcoholic steatohepatitis.

Citing Articles

Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study.

Yang X, Yan H, Guo R, Chen Y Sci Rep. 2025; 15(1):8462.

PMID: 40069258 PMC: 11897350. DOI: 10.1038/s41598-025-90818-2.


Fermented Larvae Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in C57BL/6 Mice via Regulation of Lipid Accumulation and Inflammation.

Lee H, Kim J, Go M, Lee H, Kim J, Kim I J Microbiol Biotechnol. 2025; 35:e2409025.

PMID: 39947694 PMC: 11876019. DOI: 10.4014/jmb.2409.09025.


Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization.

Yang W, Yan X, Chen R, Xin X, Ge S, Zhao Y Cell Death Dis. 2025; 16(1):58.

PMID: 39890803 PMC: 11785999. DOI: 10.1038/s41419-025-07376-8.


Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma.

Alpizar Salazar M, Olguin Reyes S, Medina Estevez A, Saturno Lobos J, De Aldecoa Castillo J, Carrera Aguas J Medicina (Kaunas). 2025; 61(1).

PMID: 39859069 PMC: 11766802. DOI: 10.3390/medicina61010088.


The Role of Quercetin, a Flavonoid in the Management of Pathogenesis Through Regulation of Oxidative Stress, Inflammation, and Biological Activities.

Alharbi H, Alshebremi M, Babiker A, Rahmani A Biomolecules. 2025; 15(1).

PMID: 39858545 PMC: 11763763. DOI: 10.3390/biom15010151.


References
1.
Chao L, MASON M, Moitra J, Vinson C, Arioglu E, Gavrilova O . Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest. 2000; 106(10):1221-8. PMC: 381440. DOI: 10.1172/JCI11245. View

2.
Hensley K, Kotake Y, Sang H, Pye Q, Wallis G, Kolker L . Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis. 2000; 21(5):983-9. DOI: 10.1093/carcin/21.5.983. View

3.
Matsusue K, Haluzik M, Lambert G, Yim S, Gavrilova O, Ward J . Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest. 2003; 111(5):737-47. PMC: 151902. DOI: 10.1172/JCI17223. View

4.
Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M . Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med. 1988; 27(2):142-9. DOI: 10.2169/internalmedicine1962.27.142. View

5.
Lin H, Yang S, Chuckaree C, Kuhajda F, Ronnet G, Diehl A . Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med. 2000; 6(9):998-1003. DOI: 10.1038/79697. View